Page 24 - Acute News Today

(1) PÉCS, Hungary and BUDAPEST, Hungary, March 04, 2021 (GLOBE NEWSWIRE) -- TurnSole Biologics (TurnSole) today announced the start of a Phase I/II open-label study for Azacytidine, initiated with a lead-in dose escalation pharmacokinetic Phase I/b part in the 20-50 mg/m2 range to evaluate safety in Hospitalized COVID-19 Patients in Severe Infection with Risk of Progression as Add-on Therapy to Standard of Care, continued with a Randomized, Controlled, Open-Label Adaptive Phase II part to De...

(1) Altasciences is pleased to support ReAlta Life Sciences by conducting a Phase I trial to evaluate RLS-0071 for treatment of Acute Lung Injury (ALI) as a result of viral infections, such as COVID-19, respiratory syncytial virus (RSV), and influenza. As part of the ReAlta ALI program underway, the Phase I trial is a single-ascending dose, randomized, double-blind, placebo-controlled, adaptive-design study to evaluate the safety, tolerability, PK, and PD of RLS-0071 in healthy subjects, pe...

New York Times: An inflammatory syndrome has erupted in some children in recent weeks.

(MENAFN - Nxtgen Reports) XYZ-research offers a comprehensive analysis of key market trends in the global ACUTE CARE NEEDLELESS CONNECTOR market. It also includes discussion on historical trends, current market status, competitive landscape, growth opportunities and challenges which are backed by factful feedbacks. Global markets continue to sink as the coronavirus spreads, reaching over 200 countries in total by the end of March. Now the outbreak continued to grow, as the number of cases in ...

XORTX Therapeutics Inc.: XORTX to Present at BIO CEO and Investor Conference; Strategies to Decrease Acute and Chronic Kidney Injury, Co-morbidity and Mortality XORTX Therapeutics Inc. XORTX" or the " Company") (CSE:XRX)(OTCQB:XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, announces that the Company is participating in the BIO CEO and Investor Digital Conference to be held virtually February 16-18, 2021. Dr. Allen Davidoff, XO...

World February 13, 2021 DUBAI: About 400,000 children under the age of five are in danger of dying of acute malnutrition in war-torn and impoverished Yemen this year, UN agencies warned on Friday. They said half of those in the most vulnerable age bracket, or 2.3 million small children, are projected to suffer from severe malnutrition. "These numbers are yet another cry for help from Yemen where each malnourished child also means a family struggling to survive," World Food Programme chief Davi...

Lahore: Primary healthcare centres in Punjab are short of female doctors and gynecology emergency services but the most glaring issue that came up in a survey of healthcare facilities in the...

RAWALPINDI: The residents of twin cities of Rawalpindi and Islamabad have been facing low gas pressure but the authorities seemingly have turned a deaf ear to the issue. More than 50 percent...

Acute Lung Injury Market Driven By Commence Bio, FirstString Research, Altor BioScience, CompleGen, Histocell, Windtree Therapeutics, S-Evans Biosciences

Global Herbal Nutraceutical Market Analysis, Application & Forecast to 2025 18/01/2021 - 09:11 Herbal nutraceutical is used as a powerful instrument in maintaining health and to act against nutritionally induced acute and chronic diseases. In the context of China-US trade war and COVID-19 epidemic, it will have a big influence on this market. Herbal Nutraceutical Report by Material, Application, and Geography – Global Forecast to 2025 is a professional and comprehensive research report on th...